Intercept Pharma (ICPT) Tops Q1 EPS by 64c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Intercept Pharma (ICPT) Tops Q1 EPS by 64c

Intercept Pharmaceuticals (ICPT) PT Raised to $223 at BMO Capital; 'Ocaliva Off to a Strong Start'

May 5, 2017 7:25 AM EDT

BMO Capital raised its price target on Intercept Pharmaceuticals (NASDAQ: ICPT) to $223.00 (from $221.00) while maintaining a Outperform rating with Ocaliva off to a strong start.

Analyst M. Ian Somaiya is raising Ocaliva estimates in 2017 and beyond based on steady demand in... More